121
Participants
Start Date
July 31, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Dexmedetomidine
Intervention group will receive Total Intravenous Dexmedetomidine as their anesthetic maintenance agent. Intravenous Dexmedetomidine 1.5ug/kg will be administered within 10 minutes and maintenance dose of 1.5ug/kg/hour continued as the sole anesthetic maintenance agent, thereafter.
Sevoflurane
Inhalation Sevoflurane will be administered as an anesthetic maintenance agent. Sevoflurane at 2 - 3 Vol% will be administered throughout the operative procedure.
Pelita Harapan University, Tangerang
Pelita Harapan University
OTHER